Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative site
mi
from
Dallas, TX
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative site
mi
from
Dallas, TX
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative site
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Galveston, TX
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Galveston, TX
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Houston, TX
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis
mi
from
San Antonio, TX
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis
mi
from
San Antonio, TX
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Charlottesville, VA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Falls Church, VA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Falls Church, VA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Lynchburg, VA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Roanoke, VA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Roanoke, VA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Seattle, WA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Seattle, WA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Morgantown, WV
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Morgantown, WV
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Alexandria, LA
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Alexandria, LA
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Caba,
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Caba,
Click here to add this to my saved trials
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated:  3/2/2018
Novartis Investigative Site
mi
from
Bronx, NY
Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in Acute Heart Failure Patients
Status: Enrolling
Updated: 3/2/2018
Novartis Investigative Site
mi
from
Bronx, NY
Click here to add this to my saved trials
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
Comparative Study of Initial Ozurdex (Dexamethasone Implant) Versus Avastin (Bevacizumab) in the Treatment of Macular Edema Following Central Retinal Vein Occlusion (CRVO)
Status: Enrolling
Updated:  3/5/2018
Retina Vitreous Center
mi
from
Toms River, NJ
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
Comparative Study of Initial Ozurdex (Dexamethasone Implant) Versus Avastin (Bevacizumab) in the Treatment of Macular Edema Following Central Retinal Vein Occlusion (CRVO)
Status: Enrolling
Updated: 3/5/2018
Retina Vitreous Center
mi
from
Toms River, NJ
Click here to add this to my saved trials
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
Comparative Study of Initial Ozurdex (Dexamethasone Implant) Versus Avastin (Bevacizumab) in the Treatment of Macular Edema Following Central Retinal Vein Occlusion (CRVO)
Status: Enrolling
Updated:  3/5/2018
Long Island Vitreoretinal Consultants
mi
from
Great Neck, NY
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
Comparative Study of Initial Ozurdex (Dexamethasone Implant) Versus Avastin (Bevacizumab) in the Treatment of Macular Edema Following Central Retinal Vein Occlusion (CRVO)
Status: Enrolling
Updated: 3/5/2018
Long Island Vitreoretinal Consultants
mi
from
Great Neck, NY
Click here to add this to my saved trials
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
Comparative Study of Initial Ozurdex (Dexamethasone Implant) Versus Avastin (Bevacizumab) in the Treatment of Macular Edema Following Central Retinal Vein Occlusion (CRVO)
Status: Enrolling
Updated:  3/5/2018
Long Island Vitreoretinal Consultants
mi
from
Hauppauge, NY
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
Comparative Study of Initial Ozurdex (Dexamethasone Implant) Versus Avastin (Bevacizumab) in the Treatment of Macular Edema Following Central Retinal Vein Occlusion (CRVO)
Status: Enrolling
Updated: 3/5/2018
Long Island Vitreoretinal Consultants
mi
from
Hauppauge, NY
Click here to add this to my saved trials
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
Comparative Study of Initial Ozurdex (Dexamethasone Implant) Versus Avastin (Bevacizumab) in the Treatment of Macular Edema Following Central Retinal Vein Occlusion (CRVO)
Status: Enrolling
Updated:  3/5/2018
Long Island Vitreoretinal Consultants
mi
from
Riverhead, NY
Comparison of Initial Ozurdex (Dexamethasone Implant) to Avastin (Bevacizumab) for Treatment of Macular Edema Caused by Central Retinal Vein Occlusion (CRVO)
Comparative Study of Initial Ozurdex (Dexamethasone Implant) Versus Avastin (Bevacizumab) in the Treatment of Macular Edema Following Central Retinal Vein Occlusion (CRVO)
Status: Enrolling
Updated: 3/5/2018
Long Island Vitreoretinal Consultants
mi
from
Riverhead, NY
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Southwestern American Indian Center
mi
from
Phoenix, AZ
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Southwestern American Indian Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Southern California
mi
from
Los Angeles, CA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Louisiana State University
mi
from
Baton Rouge, LA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Louisiana State University
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Johns Hopkins Pro-Health
mi
from
Baltimore, MD
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Johns Hopkins Pro-Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Diabetes Center
mi
from
Boston, MA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Joslin Diabetes Center
mi
from
Boston, MA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Northern Navajo Medical Center
mi
from
Shiprock, NM
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Northern Navajo Medical Center
mi
from
Shiprock, NM
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Columbia University
mi
from
New York, NY
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
The University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
The University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Miriam Hospital
mi
from
Providence, RI
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Tennessee, Memphis
mi
from
Memphis, TN
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Tennessee, Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Baylor College of Medicine
mi
from
Houston, TX
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Univ of Washington
mi
from
Seattle, WA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Barbara Davis Center / University of Colorado Denver
mi
from
Aurora, CO
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Barbara Davis Center / University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Kaiser Permanente Colorado Institute for Health Research
mi
from
Denver, CO
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Kaiser Permanente Colorado Institute for Health Research
mi
from
Denver, CO
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Atlanta Diabetes Associates
mi
from
Atlanta, GA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Atlanta Diabetes Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Massachusetts General Hospital
mi
from
Boston, MA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Joslin Diabetes Center
mi
from
Boston, MA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
University of Massachusetts Memorial Health Care
mi
from
Worcester, MA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
University of Massachusetts Memorial Health Care
mi
from
Worcester, MA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Brehm Center for Diabetes Research / University of Michigan
mi
from
Ann Arbor, MI
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Brehm Center for Diabetes Research / University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Univ of Minnesota
mi
from
Minneapolis, MN
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Albert Einstein College of Medicine/ Montefiore Medical Center
mi
from
Bronx, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Albert Einstein College of Medicine/ Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Jacobi Medical Center
mi
from
Bronx, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Jacobi Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials